<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/76CD45AC-378E-4073-94E5-C7DFBA3B4719"><gtr:id>76CD45AC-378E-4073-94E5-C7DFBA3B4719</gtr:id><gtr:name>University of Turku</gtr:name><gtr:address><gtr:line1>Turun yliopisto</gtr:line1><gtr:postCode>FI-20014</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A9EDFEC1-CA8D-47AE-8E76-6C3DB478ABF5"><gtr:id>A9EDFEC1-CA8D-47AE-8E76-6C3DB478ABF5</gtr:id><gtr:name>Austin Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/76CD45AC-378E-4073-94E5-C7DFBA3B4719"><gtr:id>76CD45AC-378E-4073-94E5-C7DFBA3B4719</gtr:id><gtr:name>University of Turku</gtr:name><gtr:address><gtr:line1>Turun yliopisto</gtr:line1><gtr:postCode>FI-20014</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Finland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A9EDFEC1-CA8D-47AE-8E76-6C3DB478ABF5"><gtr:id>A9EDFEC1-CA8D-47AE-8E76-6C3DB478ABF5</gtr:id><gtr:name>Austin Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD698BE9-1ED7-42BF-AC5D-427A5CA5851D"><gtr:id>DD698BE9-1ED7-42BF-AC5D-427A5CA5851D</gtr:id><gtr:name>Bayer</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2068ECB0-EE9E-4E7B-A0CA-492356B2594F"><gtr:id>2068ECB0-EE9E-4E7B-A0CA-492356B2594F</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Edison</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G84%2F6523"><gtr:id>0769CF3A-D95A-41F2-91E6-3B8813B96330</gtr:id><gtr:title>Imaging amyloid plaque load and glial activation in dementias using 11C-PIB and 11C-PK11195 PET</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G84/6523</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-09-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-09-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>120153</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bayer</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Bayer HealthCare</gtr:department><gtr:description>GE Healthcare</gtr:description><gtr:id>88758AF6-ED26-4902-8B2F-E6CF90419424</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>BkVhhWERq97-1</gtr:outcomeId><gtr:partnerContribution>GE Healthcare made 11C-PIB available</gtr:partnerContribution><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Life Sciences</gtr:department><gtr:description>Wolfson Molecular Imaging centre, Manchester</gtr:description><gtr:id>469B7FD5-4036-4F55-ACA3-B2A954B6134D</gtr:id><gtr:impact>- Edison P, Hinz R, Brooks DJ : Technical aspects of amyloid imaging for Alzheimer's disease: Alzheimer's Research &amp;amp; Therapy</gtr:impact><gtr:outcomeId>rXz5aGZyrH3-1</gtr:outcomeId><gtr:partnerContribution>Joint paper publication</gtr:partnerContribution><gtr:piContribution>I mage processing and analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Turku</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:department>PET Centre Turku</gtr:department><gtr:description>Turku PET centre</gtr:description><gtr:id>7A8403C1-5749-4079-A6BA-D340D905D0CF</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>Xoof4oBhwFB-1</gtr:outcomeId><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Austin Hospital</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Centre for PET</gtr:department><gtr:description>Centre for PET, Austin Health, Melbourne and Colin L Masters - Dept. Pathology, University of Melbourne</gtr:description><gtr:id>5C622A0F-EE5F-44AE-A1A4-FDFBEA705336</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>PyAusS5WaQe-1</gtr:outcomeId><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Diego (UCSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pathology</gtr:department><gtr:description>Centre for PET, Austin Health, Melbourne and Colin L Masters - Dept. Pathology, University of Melbourne</gtr:description><gtr:id>4BB922F9-6232-41D9-9875-BDBF07A23564</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>PyAusS5WaQe-2</gtr:outcomeId><gtr:piContribution>NA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>The study was headline news at 6.00pm news at BBC 1 Television on 14th July 2006</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>95131C12-1083-46B4-8B25-89994D83E831</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>EfooD4nCzqQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>John and Lucille van Geest Foundation</gtr:department><gtr:description>Evaluating the effects of the novel GLP-1 analogue, liraglutide, in patients with Alzheimer's disease (ELAD Study)</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>University of Leicester</gtr:fundingOrg><gtr:id>54511119-5AAF-4101-A7DE-9AD6D7BDFF87</gtr:id><gtr:outcomeId>5464abbf06ef01.16235449</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>245000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The role of perturbed nitric oxide signalling in disruption of the neurovascular unit of the blood brain barrier by environmental and genetic risk factors for Alzheimer's disease</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>6E8A6BF3-09D9-4064-AAAF-5E01F952EA74</gtr:id><gtr:outcomeId>5464ad5aa228f3.83025687</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>167000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A longitudinal PET study of amyloid deposition and neuroinflammation in Alzheimer's disease and Mild Cognitive Impairment patients</gtr:description><gtr:end>2008-05-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>1FFCC60D-2803-433B-8A48-40483C92D432</gtr:id><gtr:outcomeId>bKSPHMPBzWx0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2005-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>57600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Imperial College Healthcare NHS Charity</gtr:department><gtr:description>Imperial Healthcare Charity (Dementia care service improvement)</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Imperial College Healthcare NHS Trust</gtr:fundingOrg><gtr:id>8E8D7888-2DB5-4A99-9B78-5244CC2A1B14</gtr:id><gtr:outcomeId>T5npGAG3Gfd0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>67000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Genetic factors influencing earliest changes in Alzheimer's disease development</gtr:description><gtr:end>2014-03-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>19BC4497-21AB-4A72-8B51-7DCE9F592EA2</gtr:id><gtr:outcomeId>5464aac95097e3.57609260</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>24000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Imperial College VIP award</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Imperial College London</gtr:fundingOrg><gtr:id>25A8E666-3B29-4B0D-955D-A9DF3638A1D7</gtr:id><gtr:outcomeId>D49akcCFHoh0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>370000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Imaging amyloid and neuroinflammation in subjects &amp;quot;at risk&amp;quot; for Alzheimer's disease</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>29638296-51A0-4CBE-85AE-886DDDBAC232</gtr:id><gtr:outcomeId>5464b01d3753e9.25927939</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Evaluation of novel GLP-1 analogue in treatment of very mild Alzheimer's disease</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Alzheimer's Drug Discovery Foundation</gtr:fundingOrg><gtr:id>66E3B5DF-36FC-40CF-BBB9-91C1784FAF4E</gtr:id><gtr:outcomeId>5464ade88f37e6.30650400</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>255000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Evaluation of tau aggregation detected by novel tau tracer, [18F]T807 PET in mild cognitive impairment subjects: a preliminary PET study</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>B43A9271-1579-4675-A3F3-8D97C00695E7</gtr:id><gtr:outcomeId>5464ab565a1295.88430713</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>338000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Effect of Liraglutide, novel GLP-1 analogue on microglial activation and amyloid in mild Alzheimer's disease.</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Alzheimer's Association</gtr:fundingOrg><gtr:id>BA7A6E5B-F9CB-44AE-9CE7-7D4158FA5AC1</gtr:id><gtr:outcomeId>gd97N7GJSGE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The impact of GLP-1 analogues on neurodegeneration and neuroinflammation in a model of Alzheimer's disease: a two pronged therapeutic approach</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>EFF0581A-849D-4F0B-A6DF-7F2D579CC133</gtr:id><gtr:outcomeId>HX6XXPZSQur0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Evaluation of novel GLP-1 analogue in treatment of very mild Alzheimer's disease</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Novo Nordisk UK Research Foundation</gtr:fundingOrg><gtr:id>1BF066C3-622E-40DC-876E-3A873EE30E02</gtr:id><gtr:outcomeId>5464ae6e268724.80411356</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Newer imaging techniques are used for the diagnosis of dementia</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>National Institute on Aging (NIA) and the Alzheimer's Association criteria for the diagnosis of dementia</gtr:guidelineTitle><gtr:id>4EFEDC05-0226-4A30-B82F-3D7A3B426F36</gtr:id><gtr:impact>It has changed the way in which patients are enrolled into the study</gtr:impact><gtr:outcomeId>qfYpFCAjk5D</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>An automated method of analysis of PET data</gtr:description><gtr:id>F06CDDEA-0CA5-48B0-AD2C-7CDD0C8E7471</gtr:id><gtr:impact>It is widely published and other groups are using this</gtr:impact><gtr:outcomeId>hrN7sjrAa6D</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Created a novel method of analysis of the data</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>31FBD280-2009-4D2A-8111-EFC8EA9AFA24</gtr:id><gtr:title>Carcinoid-associated Encephalopathy</gtr:title><gtr:parentPublicationTitle>JOURNAL OF CLINICAL GASTROENTEROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e359640917061f9cf0245c32f168736b"><gtr:id>e359640917061f9cf0245c32f168736b</gtr:id><gtr:otherNames>Femminella Grazia D.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0192-0790</gtr:issn><gtr:outcomeId>5a3605d7412ed0.07619636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F7AA07A-5E80-4580-B7B2-8EAE5AF58986</gtr:id><gtr:title>Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b121c4c0c64cd8e2e7e65f5c4be9911"><gtr:id>0b121c4c0c64cd8e2e7e65f5c4be9911</gtr:id><gtr:otherNames>Knight WD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>e1sxGgC4Pxo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3019033E-17DC-4BA4-8C54-962F67BB7B4A</gtr:id><gtr:title>Reference region automatic extraction in dynamic [(11)C]PIB.</gtr:title><gtr:parentPublicationTitle>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77ac1be691b19b518046ec5ac32a7cdd"><gtr:id>77ac1be691b19b518046ec5ac32a7cdd</gtr:id><gtr:otherNames>Ikoma Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0271-678X</gtr:issn><gtr:outcomeId>pm_16466_26_23921900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DA989C3-BBC0-473E-82E5-C9ADEFB0ACD7</gtr:id><gtr:title>The emerging agenda of stratified medicine in neurology.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/059fb6c1cfee8b9cd6e18e106d34b4e8"><gtr:id>059fb6c1cfee8b9cd6e18e106d34b4e8</gtr:id><gtr:otherNames>Matthews PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_16466_26_24323053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DEF61C3-CB64-41E5-8C1D-6ED67D7583BD</gtr:id><gtr:title>A European multicentre PET study of fibrillar amyloid in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba65bcf035709e784cb1af64b689809f"><gtr:id>ba65bcf035709e784cb1af64b689809f</gtr:id><gtr:otherNames>Nordberg A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>pm_16466_26_22961445</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FD91D6A-E489-4A55-B4A4-DA5F4336BA19</gtr:id><gtr:title>Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/318097b3d5edbae2eea3f080430dde67"><gtr:id>318097b3d5edbae2eea3f080430dde67</gtr:id><gtr:otherNames>Okello A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>FcPFtpTScb5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27420FE2-7035-4625-8248-A7C7CFE42689</gtr:id><gtr:title>Reference and target region modeling of [11C]-(R)-PK11195 brain studies.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6388bd935e8af8c0bb4d3186f2a3278a"><gtr:id>6388bd935e8af8c0bb4d3186f2a3278a</gtr:id><gtr:otherNames>Turkheimer FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>tkgzVaeVcjo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C81EDCB-BFBA-40AC-BFAE-AB8F3BEBCBEE</gtr:id><gtr:title>Carcinoid-associated encephalopathy.</gtr:title><gtr:parentPublicationTitle>Journal of clinical gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c35d7bd686851bc183a51f1610d29ad"><gtr:id>2c35d7bd686851bc183a51f1610d29ad</gtr:id><gtr:otherNames>Femminella GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0192-0790</gtr:issn><gtr:outcomeId>5a3545d1deb7e2.40914694</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0793AD41-1DBB-4598-BE80-5506CF410CCD</gtr:id><gtr:title>Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c35d7bd686851bc183a51f1610d29ad"><gtr:id>2c35d7bd686851bc183a51f1610d29ad</gtr:id><gtr:otherNames>Femminella GD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>546208443ff177.37972599</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6512109B-4EDA-4489-BFC2-11CB3D79126D</gtr:id><gtr:title>Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49d1ebc4c13ad82ac9c46d6d8f88adf6"><gtr:id>49d1ebc4c13ad82ac9c46d6d8f88adf6</gtr:id><gtr:otherNames>Tomasi G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0161-5505</gtr:issn><gtr:outcomeId>pUiFVCaLc9x</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5FB5404-F57B-43F4-A075-1B22AB8CB6F0</gtr:id><gtr:title>Drug repositioning for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b687dcecbd79609cc9a44b6b5d2bf20"><gtr:id>6b687dcecbd79609cc9a44b6b5d2bf20</gtr:id><gtr:otherNames>Corbett A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-1776</gtr:issn><gtr:outcomeId>pm_16466_26_23123941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAF5635F-8267-4495-8326-82B7FF107C7E</gtr:id><gtr:title>Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47adce141336e8a72143ae842018daeb"><gtr:id>47adce141336e8a72143ae842018daeb</gtr:id><gtr:otherNames>Archer HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>a4rYwEbnHG6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CABE5764-2CF2-4DCA-B28F-86AEBD0D1DB5</gtr:id><gtr:title>Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>pm_16466_26_22306804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16959154-790F-46E8-BE76-789FF3E41121</gtr:id><gtr:title>Strategies for the generation of parametric images of [11C]PIB with plasma input functions considering discriminations and reproducibility.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>cKfzmqHVswm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C88C60D5-A25B-4767-A2EA-944B83901F96</gtr:id><gtr:title>Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4752b222bbdee97e09071550d9255907"><gtr:id>4752b222bbdee97e09071550d9255907</gtr:id><gtr:otherNames>Fan Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>546209e2dadee2.41648789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73C65F7D-587A-4580-AF66-9B7266EF46C8</gtr:id><gtr:title>Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>Zfkjir38cyY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03FC034B-7C41-42B2-9D8D-B34BDEE0D17B</gtr:id><gtr:title>Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>gFRsoj21kXE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37C4B1B5-F7D7-429D-961A-E87F80ED7E8F</gtr:id><gtr:title>Technical aspects of amyloid imaging for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Alzheimer's research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>WAFQ1MJLDqV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D1E4301-E4AB-4778-9A39-2B073FCCAA48</gtr:id><gtr:title>Microglial activation and amyloid deposition in mild cognitive impairment: a PET study.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/318097b3d5edbae2eea3f080430dde67"><gtr:id>318097b3d5edbae2eea3f080430dde67</gtr:id><gtr:otherNames>Okello A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>KaftaKG8BEv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD96B405-3D18-4CDB-8E4D-D9D163CA7447</gtr:id><gtr:title>Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>kW5fJTLhhjT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D34EE6E-84E5-4BFE-9F48-1104C0F854A9</gtr:id><gtr:title>Cortical hypermetabolism in MCI subjects: a compensatory mechanism?</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c60962ad2e8c5442613f8227292260b2"><gtr:id>c60962ad2e8c5442613f8227292260b2</gtr:id><gtr:otherNames>Ashraf A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn><gtr:outcomeId>54620b50a8ba41.58470109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F0AFE68-CCBD-4C13-8D29-F4CDFFEE6234</gtr:id><gtr:title>Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f05d5c8816acacbd274481d87778e2e"><gtr:id>5f05d5c8816acacbd274481d87778e2e</gtr:id><gtr:otherNames>Edison P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>pm_16466_26_23303049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D7CC53A-6847-4D8C-865E-0ED147245FD2</gtr:id><gtr:title>The role of neuroinflammation in dementias.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d08e5f66000f2112efaf9ece95383a2e"><gtr:id>d08e5f66000f2112efaf9ece95383a2e</gtr:id><gtr:otherNames>Pasqualetti G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn><gtr:outcomeId>54620be1ac3c22.14453291</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABBD383C-69BB-4930-999B-53EA1A4E6223</gtr:id><gtr:title>A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195.</gtr:title><gtr:parentPublicationTitle>NeuroImage</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f22d542e94b10777a522a0ea2dd10c81"><gtr:id>f22d542e94b10777a522a0ea2dd10c81</gtr:id><gtr:otherNames>Anderson AN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1053-8119</gtr:issn><gtr:outcomeId>Koo7g9BPdWh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F3516F8-7006-4F91-9C86-D872C5311D1B</gtr:id><gtr:title>11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2df16c0b13c37700a2c612d047aa21f4"><gtr:id>2df16c0b13c37700a2c612d047aa21f4</gtr:id><gtr:otherNames>Hyare H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>CHHatkeviyM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F94E9E6-FA96-43A0-B3A1-27DABD0B9133</gtr:id><gtr:title>Improving recruitment of older people to research through good practice.</gtr:title><gtr:parentPublicationTitle>Age and ageing</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa27ba2e7f5844cadc6f9f54be45b106"><gtr:id>fa27ba2e7f5844cadc6f9f54be45b106</gtr:id><gtr:otherNames>McMurdo ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-0729</gtr:issn><gtr:outcomeId>pm_16466_26_21911335</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7D314B1-E4A8-4248-B20D-9DC078816591</gtr:id><gtr:title>Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/193668764a5f7c21dd27965e246dd888"><gtr:id>193668764a5f7c21dd27965e246dd888</gtr:id><gtr:otherNames>Varley J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-5260</gtr:issn><gtr:outcomeId>54620aa6671b53.87942045</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16BCA2F4-DC2D-4257-84FB-1867AA16317F</gtr:id><gtr:title>(11)C-PIB PET in subjective cognitive impairment.</gtr:title><gtr:parentPublicationTitle>European psychiatry : the journal of the Association of European Psychiatrists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ba819c516fec5c273c4647ca9113560"><gtr:id>1ba819c516fec5c273c4647ca9113560</gtr:id><gtr:otherNames>Rodda J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0924-9338</gtr:issn><gtr:outcomeId>F9ebM1TS3Gj</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G84/6523</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>